Histopathology and proteomics are synergistic for high-grade serous ovarian cancer platinum response prediction

Abstract Patients with High-Grade Serous Ovarian Cancer (HGSOC) exhibit varied responses to treatment, with 20–30% showing de novo resistance to platinum-based chemotherapy. While hematoxylin-eosin (H&E)-stained pathological slides are used for routine diagnosis of cancer type, they may also con...

Full description

Bibliographic Details

Published in:	npj Precision Oncology
Main Authors:	Oz Kilim, Alex Olar, András Biricz, Lilla Madaras, Péter Pollner, Zoltán Szállási, Zsofia Sztupinszki, István Csabai
Format:	Article
Language:	English
Published:	Nature Portfolio 2025-01-01
Online Access:	https://doi.org/10.1038/s41698-025-00808-w